Myovant Sciences EBITDA Margin 2017-2022 | MYOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Myovant Sciences (MYOV) over the last 10 years. The current EBITDA margin for Myovant Sciences as of December 31, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-12-31 | $0.38B | $-0.14B | -37.47% |
| 2022-09-30 | $0.33B | $-0.15B | -45.05% |
| 2022-06-30 | $0.31B | $-0.14B | -44.12% |
| 2022-03-31 | $0.23B | $-0.18B | -79.22% |
| 2021-12-31 | $0.20B | $-0.21B | -106.06% |
| 2021-09-30 | $0.15B | $-0.23B | -157.93% |
| 2021-03-31 | $0.06B | $-0.26B | -437.29% |
